Defining an optimal model for European distribution

A-Medica has developed methods for identifying an “optimal” distribution model for a given product in its market(s), as a function of market and product characteristics, the competitive situation as well as implications from the internal organization.

The whole value-chain of activities, from product prototyping up till assuring the key success criteria in each target market like selling-in to end users, requires a careful assessment and design to assure the markets’ volume and value potential will indeed be captured.

PRE-MARKET
- Prototyping
- Efficacy validation
- Regulatory clearance (CE-mark, EMEA, FDA, …)
- Economic model (reimbursement, DRG, …)
- Final product design
- Manufacturing

BACK-OFFICE
- Authorizations and certifications
- Credit control
- Invoicing - VAT administration
- Payment control
- Inventory management
- Reporting

LOGISTICS & DISTRIBUTION
- Importation
- Warehousing
- Distribution
- Return of goods

MARKETING & SALES
- Selling-in
- Training of users
- After-sales service

The design and validation of the above key actions should also captured which activities need delivery at or close to end-users location versus those that might be provided from a central location, as well as which activities require capabilities within the organization as opposed to procurement of out-sourced services.